Astel­las los­es patent in­fringe­ment case over block­buster blad­der drug

Astel­las just faced a set­back in fed­er­al court — with a judge in­val­i­dat­ing three claims on a patent sur­round­ing an ex­tend­ed re­lease ver­sion of its block­buster …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA